Trial Profile
Real-life Data of Sorafenib in Unresectable Hepatocellular Carcinoma: Retrospective Analysis of 511 Consecutive Patients Treated with Sorafenib in a Single Tertiary Referral Center
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Nov 2015
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Adverse reactions; Therapeutic Use
- 02 Nov 2015 New trial record